Neurolex was acquired by Sonde Health in August of 2020. NeuroLex Labs is a health startup that collects and analyzes speech and text samples to detect various health conditions early, before full-blown symptoms appear.In doing so, NeuroLex Labs aims to improve health outcomes and lower overall healthcare costs. Their initial use cases are inpsychiatry (detecting bipolar disorder, depression, psychosis, anxiety, and addiction/substance abuse).

NeuroLex Laboratories

Similar companies